ReviewCurrent neuropharmacology2021

Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer's and Parkinson's Diseases.

Sonia Mayo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.